Top Buy
Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | €705.70 | €766.92 | 8.674% |
MacroGenics Inc. | 14 | 1 | 5 | 1 | €3.07 | €14.25 | 363.696% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
Biogen Inc. | 46 | 1 | 6 | 1 | €205.70 | €294.01 | 42.932% |
Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €392.60 | €406.87 | 3.634% |
Neurocrine Bioscience | 28 | 0 | 7 | 0 | €126.90 | €140.34 | 10.591% |
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €60.50 | €79.55 | 31.495% |